{
  "cik": "0001321834",
  "name": "TNF Pharmaceuticals, Inc.",
  "entityType": "operating",
  "sic": "2835",
  "sicDescription": "In Vitro & In Vivo Diagnostic Substances",
  "stateOfIncorporation": "DE",
  "stateOfIncorporationDescription": "DE",
  "fiscalYearEnd": "1231",
  "tickers": [
    "TNFA"
  ],
  "exchanges": [
    "Nasdaq"
  ],
  "ein": "000000000",
  "description": "",
  "website": "",
  "investorWebsite": "",
  "category": "Non-accelerated filer<br>Smaller reporting company",
  "phone": "856-848-8698",
  "flags": "",
  "formerNames": [
    {
      "name": "MyMD Pharmaceuticals, Inc.",
      "from": "2021-04-16T04:00:00.000Z",
      "to": "2024-07-01T04:00:00.000Z"
    },
    {
      "name": "Akers Biosciences, Inc.",
      "from": "2017-04-13T04:00:00.000Z",
      "to": "2021-04-16T04:00:00.000Z"
    },
    {
      "name": "Akers Biosciences Inc",
      "from": "2005-03-23T05:00:00.000Z",
      "to": "2017-04-11T04:00:00.000Z"
    }
  ],
  "filings_count": 540,
  "download_timestamp": "2025-08-02 07:10:27 UTC"
}